Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Akebia Therapeutics, Inc. (AKBA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 09/26/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/25/2023 |
8-K
| Quarterly results |
| 08/17/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 08/11/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
3
| Snow Ellen (SVP, CFO and Treasurer) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 07/18/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/08/2023 |
4
| ZUMWALT LEANNE M (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| FRIESON RON (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| Wolf Myles (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/07/2023 |
8-K
| Investor presentation |
| 06/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/02/2023 |
8-K
| Other Events Interactive Data |
| 05/31/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 05/25/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Sold 63,186 shares
@ $1.2229, valued at
$77.3k
Granted 200,000 options to buy
@ $0.41, valued at
$82k
|
|
| 05/25/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Sold 95,478 shares
@ $1.2229, valued at
$116.8k
Granted 200,000 options to buy
@ $0.41, valued at
$82k
|
|
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/25/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 05/23/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/18/2023 |
4
| Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 63,567 shares
@ $1.068, valued at
$67.9k
|
|
| 05/18/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 63,567 shares
@ $1.068, valued at
$67.9k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
|
|
|